Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Update Il y a 4 ans
Reference: NCT00809614

Woman and Man

Extract

This study is designed as a proof of concept of AIN457 in patients with psoriatic arthritis. The study will address the evaluation of the efficacy at 6 and up to 24 weeks after two doses of AIN457 10 mg/kg administered three weeks apart.


Inclusion criteria

  • Psoriatic Arthritis

Links